title: Daclatasvir plus sofosbuvir regimen sheds promising light on future hepatitis C virus genotype 3 therapies.
authors.affiliation: Division of Gastroenterology and Hepatology, University of Missouri, Columbia, Missouri, USA. veyseltahan@yahoo.com.
authors.forename: Ali Murat
authors.initials: AM
authors.lastname: Kahveci
authors.forename: Veysel
authors.initials: V
authors.lastname: Tahan
mesh_terms: D000998:Antiviral Agents / Q000627:therapeutic use; D004359:Drug Therapy, Combination; D005838:Genotype; D016174:Hepacivirus / Q000235:genetics*; D019698:Hepatitis C, Chronic / Q000188:drug therapy; D006801:Humans; D000069474:Sofosbuvir
chemical_list: D000998:Antiviral Agents; D000069474:Sofosbuvir